← Leaderboards
Baohua Zhou
Indiana Univ-Purdue Univ At Indianapolis
$6,666,422
Attributed
$8,594,301
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,594,301 · 8
By mechanism
R01$7,117,031 · 3
R21$1,276,447 · 3
P30$200,823 · 2
Top collaborators
- Mateusz Opyrchal3 shared
- Xinna Zhang3 shared
- Mark H. Kaplan2 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Robert S. Tepper$17,766,613
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAsthmaMediatingRegulatory T-LymphocyteCd4 Positive T LymphocytesHypersensitivityPlayAllergic DiseaseIn VivoCytokineAntigensIn VitroAffectRegulationAllergic Airway InflammationAllergensImmunityAllergicResponsePreventPathogenesisBaseDesignTherapeutic Target
Grant awards (23)
FOXP3 ÎE2 isoform in asthma severity and persistence$776,962
R01 · FY2025 · AI · contact PI
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy$585,212
R01 · FY2025 · CA · contact PI
Flow Cytometry Core$92,561
P30 · FY2025 · CA · contact PI
FOXP3 ÎE2 isoform in asthma severity and persistence$776,962
R01 · FY2024 · AI · contact PI
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy$555,952
R01 · FY2024 · CA · contact PI
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy$585,212
R01 · FY2023 · CA · contact PI
Flow Cytometry Resource Facility$108,262
P30 · FY2023 · CA · contact PI
FOXP3 ÎE2 Isoform in Treg Function and Pathophysiology of Lupus$198,125
R21 · FY2022 · AI · contact PI
FOXP3 ÎE2 Isoform in Treg Function and Pathophysiology of Lupus$237,750
R21 · FY2021 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$390,000
R01 · FY2019 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$390,000
R01 · FY2018 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$390,000
R01 · FY2017 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$390,000
R01 · FY2016 · AI · contact PI
FOXP3 Regulates RNA Alternative Splicing in Tregs$234,000
R21 · FY2016 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$390,000
R01 · FY2015 · AI · contact PI
FOXP3 Regulates RNA Alternative Splicing in Tregs$195,000
R21 · FY2015 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$381,150
R01 · FY2014 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$358,281
R01 · FY2013 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$381,150
R01 · FY2012 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$381,150
R01 · FY2011 · AI · contact PI
TSLP in Th2 Immunity and Allergic Airway Inflammation$385,000
R01 · FY2010 · AI · contact PI
Exploring TSLP as a Key Initiator and Novel Therapeutic Target for Asthma$222,197
R21 · FY2008 · AI · contact PI
Exploring TSLP as a Key Initiator and Novel Therapeutic Target for Asthma$189,375
R21 · FY2007 · AI · contact PI